Frequency of troponin elevations in patients with influenza infection during the 2017–2018 influenza season

Abstract

BackgroundWith the increased number of influenza cases observed during the 2017 – 2018 season, patients may be at a greater risk of cardiac related complications as a sequela of viral illness. We described the frequency of troponin elevations in patients with influenza infection during the 2017 – 2018 influenza season.MethodsThis was a retrospective, single-center observational study. All patients aged 18 years or older and had laboratory confirmed influenza viral infection were included in the study. Troponins were considered elevated if greater than 0.3 ng/mL. Electronic health records were reviewed for demographics, laboratory values, coronary artery disease history, electrocardiography, echocardiography results, and incidence of inpatient mortality.ResultsA total of 1,131 patients had lab confirmed influenza infection. Majority of the influenza strains were influenza A, 76.2% (n = 863), and the rest of the influenza strains comprised of influenza B, 23.8% (n = 270). Thirty three (2.9%) patients had elevation of troponin levels greater than 0.3 ng/mL. Most of the patients with elevated troponin levels had influenza A infection (90.9%, n = 30), of which H3 subtype was the most common (48.5%, n = 16). Fifteen patients (45.5%) had a myocardial infarction, 20 (60.6%) had left ventricular abnormalities visualized on echocardiogram, and four (12.1%) died while inpatient.ConclusionsOur results describe the frequency of troponin elevations in patients with influenza infection at our institution during the 2017 – 2018 influenza season.

Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty

“…Alternatively, the observed incidence of myocardial injury could be due to the increased risk of myocardial ischemic insult due to the poorly understood pleiotropic prothrombotic inflammatory sequelae from viral infections. An increased risk of myocardial infarction as determined by serological evidence of myocardial injuries has been welldocumented in influenza infections at similar prevalence [30][31][32]. This would suggest that the intravascular prothrombotic effect observed in COVID-19 patients is the consequence of the overall inflammatory state rather than a COVID19-specific phenomenon.…”

Coronaviruses and the cardiovascular system: acute and long-term implications

“…Electrocardiographic changes and troponin elevation may signal underlying myocarditis, and echocardiography frequently demonstrates sub-clinical left ventricular diastolic impairment (with a higher likelihood of the need for mechanical ventilation in those with systolic impairment and reduced ejection fraction). 7 , 12 …”

COVID‐19 and the heart: An update for clinicians

“…Underlying myocarditis has been described with electrocardiographic changes, troponin elevation, and echocardiographic evidence of diastolic and systolic dysfunction. In previous coronavirus epidemics, adverse outcomes including hypotension, arrhythmia, and sudden cardiac death have been reported in patients with pre‐existing cardiovascular disease 5 …”

“…In previous coronavirus epidemics, adverse outcomes including hypotension, arrhythmia, and sudden cardiac death have been reported in patients with pre-existing cardiovascular disease. 5 Patients with pre-existing comorbidities are thought to be at an increased risk of infection with SARS-CoV2 and also tend to have worse clinical outcomes. Specifically, patients with cardiovascular disease, diabetes and hypertension are thought to have a high complication rate with mortality rate of 10.5% reported in cardiac patients and mortality rates of 7.3% and 6.0% for diabetes and hypertension patients, respectively.…”